Growth Metrics

Pfizer (PFE) Shares Outstanding (2018 - 2025)

Pfizer (PFE) has disclosed Shares Outstanding for 13 consecutive years, with $3.9 billion as the latest value for Q2 2022.

  • On a quarterly basis, Shares Outstanding rose 1.35% to $3.9 billion in Q2 2022 year-over-year; TTM through Apr 2022 was $3.9 billion, a 1.35% increase, with the full-year FY2021 number at $3.9 billion, down 59.06% from a year prior.
  • Shares Outstanding was $3.9 billion for Q2 2022 at Pfizer, down from $9.5 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $9.5 billion in Q4 2021 to a low of -$3.5 billion in Q3 2018.
  • A 5-year average of $5.5 billion and a median of $6.6 billion in 2018 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: plummeted 100.0% in 2019, then surged 923501099.04% in 2021.
  • Pfizer's Shares Outstanding stood at $9.3 billion in 2018, then plummeted by 58.9% to $3.8 billion in 2019, then surged by 145.29% to $9.4 billion in 2020, then tumbled by 59.06% to $3.9 billion in 2021, then rose by 1.35% to $3.9 billion in 2022.
  • Per Business Quant, the three most recent readings for PFE's Shares Outstanding are $3.9 billion (Q2 2022), $3.9 billion (Q4 2021), and $9.5 billion (Q4 2021).